Enzamide 40mg Capsule

About Enzamide 40mg Capsule

Enzamide 40mg Capsule contains Enzalutamide, a targeted anticancer medication belonging to the androgen receptor inhibitor class, used for the treatment of advanced prostate cancer in adult men, particularly when the disease no longer responds effectively to surgical or hormonal therapies. It works by blocking the action of male hormones (androgens) that promote the growth and spread of prostate cancer cells, helping to slow disease progression and improve treatment outcomes. Patients should not use Enzamide 40mg Capsule if they are allergic to Enzalutamide or any of its ingredients. During treatment, healthcare providers may regularly monitor prostate-specific antigen (PSA) levels, liver function tests, and complete blood counts (CBC) to evaluate treatment response and identify potential side effects early. Patients with a history of seizures should inform their doctor before starting therapy, as Enzalutamide may increase the risk of seizure activity. Grapefruit and grapefruit juice should be avoided during treatment because they can increase the concentration of the medication in the body and raise the likelihood of side effects. This medicine may cause harm to an unborn baby and can also affect fertility; therefore, patients should discuss fertility preservation and family planning options with their healthcare provider before treatment begins. Effective contraception is recommended for both men and women during treatment and for at least three months after the final dose. Regular medical monitoring and adherence to prescribed therapy are essential to ensure the safe and effective use of Enzamide 40mg Capsule in the management of advanced prostate cancer.